Search

  • HOME
  • Search
Review
1499
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
Chung-Feng Huang, Ming-Lung Yu
Clin Mol Hepatol. 2020;26(3):251-260.   Published online March 19, 2020
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
Nadia Marascio, Angela Quirino, Giorgio Settimo Barreca, Luisa Galati, Chiara Costa, Vincenzo Pisani, Maria Mazzitelli, Giovanni Matera, Maria Carla Liberto, Alfredo Focà, Carlo Torti
Clin Mol Hepatol. 2019;25(1):30-36.   Published online January 23, 2019
1325
Management of direct antiviral agent failures
María Buti, Rafael Esteban
Clin Mol Hepatol. 2016;22(4):432-438.   Published online December 25, 2016
Original Article
1303
Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection
Hee Chul Nam, Hae Lim Lee, Hyun Yang, Myeong Jun Song
Clin Mol Hepatol. 2016;22(2):259-266.   Published online June 25, 2016
Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea
Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
Clin Mol Hepatol. 2015;21(4):358-364.   Published online December 24, 2015
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 35
TOTAL : 696321
Close layer